All news from Anaesthesiology
The seizures typically begin in the first months of life. It often takes years, however, before those suffering from the rare glucose transporter type 1 (Glut1) deficiency syndrome obtain a correct diagnosis. If the disorder goes untreated, affected children experience developmental delay and frequently have neurological problems.
Various defects in one gene underlie the syndrome. They cause the Glut1 protein to lose its function in the cell membrane: the protein no longer transports glucose from the blood into the brain. The study was published in the current issue of the journal Cell
Researchers have identified a system of communication networks that exist among organs and tissues that regulate metabolism. Findings from their study provide, for the first time, a detailed "atlas" illustrating how the body creates and uses energy, and how imbalances in the networks may impact overall health.
The study was published in the journal Cell. The research reveals the highly coordinated, multi-tissue metabolism underlying the body's circadian rhythms and examines how disruptions in these rhythms such as those caused by high-fat diets induce misalignment among the network clocks and can trigger inflammation, which has been linked to major diseases and can affect lifespan.
Following a row of major health developments, the Nepal Health Research Council (NHRC) has urged the government to formulate health policies based on ‘scientific research data’.
According to a study, researchers examine emergency department providers need evidence-based strategies to identify and manage patients with opioid use disorder. The study was published in the Annals of Emergency Medicine.
A new study by researchers at Intermountain Healthcare in Salt Lake City has found that patients with low-risk blood clots may be better off receiving treatment at home versus being admitted to the hospital.
A study in adolescent girls reports that recent life events impact depressive symptoms differently, depending on how the brain responds to winning and losing. A strong brain response to winning boosted the beneficial impact of positive experiences on symptoms, whereas a strong response to losing enhanced the detrimental impact of negative experiences on symptoms. The study was published in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging.
A blood test that quickly and easily detects whether a person is at risk of a second heart attack is being developed by scientists at the Baker Heart and Diabetes Institute. The study has been published in JCI Insight.
The researcher found that out of 752 genes which regulate lungs in mice, 230 genes work only in the day and only 197 at night. And in the liver, where doctors have long thought that steroids are influential for many side effects, 1,702 genes regulate the organ in the day and a mere 299 at night in mice.
The research could one day have important implications on the way steroids one of the most common drugs in medicine are prescribed. The study was published in the Journal of Clinical Investigation.
Ayushman Bharat rests on the twin pillars of Health and Wellness Centres for provision of comprehensive primary healthcare services and the Prime Minister's National Health Protection Mission for secondary and tertiary care to 100 million families.
It's a silent, sudden and almost assured killer: a thoracic aortic aneurysm (TAA) occurs when a weak spot or bulge in the body's main pipeline for pumping blood suddenly ruptures, cutting off the supply of life-sustaining blood and flooding the chest or abdomen with it.
Teens who took a supplemental drivers' ed program — including tours of emergency rooms, ICUs and a morgue — showed more awareness of the consequences of risky driving and of how they can avoid dangers. But data from a two-month follow-up to the program was inconclusive as to whether the program made a difference in the youths' behavior behind the wheel.
The US Food and Drug Administration (FDA) has approved two new oral treatments for adults with HIV-1 infection, Pifeltro and Delstrigo, both from Merck & Co, according to a company news release.
